Ferrández, Maria C.; Golla, Sandeep S. V.; Eertink, Jakoba J.; de Vries, Bart M.; Lugtenburg, Pieternella J.; Wiegers, Sanne E.; Zwezerijnen, Gerben J. C.; Pieplenbosch, Simone; Kurch, Lars; Hüttmann, Andreas; Hanoun, Christine; Dührsen, Ulrich; de Vet, Henrica C. W.; Josée M., Zijlstra; Ronald, Boellaard:
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
In: Scientific Reports, Vol. 13 (2023), No. 1, Article 13111
2023article/chapter in journalOA Gold
MedicineFaculty of Medicine » Essen University Hospital » Clinic for HematologyFaculty of Medicine » Essen University Hospital » Westdeutsches Tumorzentrum Essen (WTZ)Scientific institutes » Center of Medical Biotechnology (ZMB)
Related: 1 publication(s)
Title in English:
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
Author:
Ferrández, Maria C.
Other
corresponding author
;
Golla, Sandeep S. V.
;
Eertink, Jakoba J.
;
de Vries, Bart M.
;
Lugtenburg, Pieternella J.
;
Wiegers, Sanne E.
;
Zwezerijnen, Gerben J. C.
;
Pieplenbosch, Simone
;
Kurch, Lars
;
Hüttmann, AndreasUDE
LSF ID
12928
ORCID
0000-0003-2230-3873ORCID iD
Other
connected with university
;
Hanoun, Christine
;
Dührsen, UlrichUDE
GND
1073185001
LSF ID
14454
ORCID
0000-0002-4034-9472ORCID iD
Other
connected with university
;
de Vet, Henrica C. W.
;
Josée M., Zijlstra;Ronald, Boellaard
Contributor:
PETRA
Year of publication:
2023
Open Access?:
OA Gold
Web of Science ID
PubMed ID
Scopus ID
Note:
CA extern
Language of text:
English

Abstract in English:

Convolutional neural networks (CNNs) may improve response prediction in diffuse large B-cell lymphoma (DLBCL). The aim of this study was to investigate the feasibility of a CNN using maximum intensity projection (MIP) images from ¹⁸F-fluorodeoxyglucose (¹⁸F-FDG) positron emission tomography (PET) baseline scans to predict the probability of time-to-progression (TTP) within 2 years and compare it with the International Prognostic Index (IPI), i.e. a clinically used score. 296 DLBCL ¹⁸F-FDG PET/CT baseline scans collected from a prospective clinical trial (HOVON-84) were analysed. Cross-validation was performed using coronal and sagittal MIPs. An external dataset (340 DLBCL patients) was used to validate the model. Association between the probabilities, metabolic tumour volume and Dmaxbulk was assessed. Probabilities for PET scans with synthetically removed tumors were also assessed. The CNN provided a 2-year TTP prediction with an area under the curve (AUC) of 0.74, outperforming the IPI-based model (AUC = 0.68). Furthermore, high probabilities (> 0.6) of the original MIPs were considerably decreased after removing the tumours (< 0.4, generally). These findings suggest that MIP-based CNNs are able to predict treatment outcome in DLBCL.